XML 61 R49.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Licenses and Collaborations - Additional Information (Detail) - USD ($) $ in Thousands |  | 3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | ---
Oct. 31, 2020 | Jun. 30, 2024 | Mar. 31, 2024 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2021 | Dec. 31, 2020
License and Collaborations [Line Items] |  |  |  |  |  |  |  |  |  |
Research and development |  | $ 29,311 |  | $ 16,231 |  | $ 52,511 | $ 41,340 |  |  |
Ares Trading S A [Member] | Achievement Of Specified BLA Filing Or Regulatory Approval Milestones [Member] |  |  |  |  |  |  |  |  |  |
License and Collaborations [Line Items] |  |  |  |  |  |  |  |  |  |
Milestone payments payable |  |  |  |  |  |  |  |  |  | $ 15,000
Ares Agreement [Member] | Ares Trading S A [Member] |  |  |  |  |  |  |  |  |  |
License and Collaborations [Line Items] |  |  |  |  |  |  |  |  |  |
Milestone payments payable |  |  |  |  |  |  |  |  |  | 25,000
Related party transaction, expenses from transactions with related party |  |  | $ 100 |  | $ 1,100 | 200 | $ 2,000 |  |  |
Ares Agreement [Member] | Ares Trading S A [Member] | Achievement Of Specified BLA Filing Or Regulatory Approval Milestones [Member] |  |  |  |  |  |  |  |  |  |
License and Collaborations [Line Items] |  |  |  |  |  |  |  |  |  |
Milestone payments payable |  |  |  |  |  |  |  |  |  | 176,500
Ares Agreement [Member] | Ares Trading S A [Member] | Achievement Of Specified Commercial Milestones [Member] |  |  |  |  |  |  |  |  |  |
License and Collaborations [Line Items] |  |  |  |  |  |  |  |  |  |
Milestone payments payable |  |  |  |  |  |  |  |  |  | 515,000
Ares Agreement [Member] | Ares Trading S A [Member] | Regulatory Approval In The U.S [Member] |  |  |  |  |  |  |  |  |  |
License and Collaborations [Line Items] |  |  |  |  |  |  |  |  |  |
Milestone payments payable |  |  |  |  |  |  |  |  |  | $ 20,000
Amplyx Agreement [Member] |  |  |  |  |  |  |  |  |  |
License and Collaborations [Line Items] |  |  |  |  |  |  |  |  |  |
Milestone payments payable |  |  |  |  |  |  |  |  | $ 2,000 |
Acquisition cost |  |  |  |  |  |  |  |  | 5,000 |
Research and development |  |  |  |  |  |  |  |  | 7,000 |
Reduction in contingent future development |  |  |  |  |  |  |  | $ 7,000 |  |
Contingent milestone obligation accrued |  |  |  |  |  |  |  |  | $ 2,000 |
Company shares issued |  |  |  |  |  |  |  | $ 5,700 |  |
Amplyx Agreement [Member] | Amplyx and Novartis [Member] | Achievement of Various Clinical Development and Regulatory Milestones [Member] |  |  |  |  |  |  |  |  |  |
License and Collaborations [Line Items] |  |  |  |  |  |  |  |  |  |
Milestone payments payable |  | 7,000 |  |  |  | 7,000 |  |  |  |
Novartis [Member] | Amplyx and Novartis [Member] | Achievement of Various Clinical Development and Regulatory Milestones [Member] |  |  |  |  |  |  |  |  |  |
License and Collaborations [Line Items] |  |  |  |  |  |  |  |  |  |
Milestone payments payable |  | $ 62,000 |  |  |  | $ 62,000 |  |  |  |
Series C [Member] | Ares Agreement [Member] | Ares Trading S A [Member] |  |  |  |  |  |  |  |  |  |
License and Collaborations [Line Items] |  |  |  |  |  |  |  |  |  |
Temporary equity stock shares issued during the period shares | 1,913,501 |  |  |  |  |  |  |  |  |
Temporary equity shares issued during the period value | $ 13,100 |  |  |  |  |  |  |  |  |
Common Class A [Member] |  |  |  |  |  |  |  |  |  |
License and Collaborations [Line Items] |  |  |  |  |  |  |  |  |  |
Company shares issued |  |  |  |  |  |  |  | 283,034 |  |

X
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 23 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479405/805-10-25-23 + Details
Name: | us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. + References No definition available. + Details
Name: | us-gaap_OperatingCostsAndExpenses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 912 -SubTopic 730 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1 + Details
Name: | us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Value of new stock classified as temporary equity issued during the period. + References No definition available. + Details
Name: | us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Contingent Milestone Obligation Accrued + References No definition available. + Details
Name: | vera_ContingentMilestoneObligationAccrued
Namespace Prefix: | vera_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition License and collaborations. + References No definition available. + Details
Name: | vera_LicenseAndCollaborationsLineItems
Namespace Prefix: | vera_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Milestone payments payable. + References No definition available. + Details
Name: | vera_MilestonePaymentsPayable
Namespace Prefix: | vera_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Reduction In Contingent Future Development + References No definition available. + Details
Name: | vera_ReductionInContingentFutureDevelopment
Namespace Prefix: | vera_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Stock issued during period shares licensing payments in equity. + References No definition available. + Details
Name: | vera_StockIssuedDuringPeriodSharesLicensingPaymentsInEquity
Namespace Prefix: | vera_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock Issued During Period Shares Licensing Payments In Equity (value) + References No definition available. + Details
Name: | vera_StockIssuedDuringPeriodSharesLicensingPaymentsInEquityValue
Namespace Prefix: | vera_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Temporary equity stock shares issued during the period shares. + References No definition available. + Details
Name: | vera_TemporaryEquityStockSharesIssuedDuringThePeriodShares
Namespace Prefix: | vera_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vera_AresTradingSAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | vera_EventAxis=vera_AchievementOfSpecifiedBlaFilingOrRegulatoryApprovalMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | vera_AgreementAxis=vera_AresAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | vera_EventAxis=vera_AchievementOfSpecifiedCommercialMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | vera_EventAxis=vera_RegulatoryApprovalInTheUSMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | vera_AgreementAxis=vera_AmplyxAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vera_AmplyxAndNovartisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | vera_EventAxis=vera_AchievementOfVariousClinicalDevelopmentAndRegulatoryMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | vera_AgreementAxis=vera_NovartisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=vera_SeriesCRedeemableConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |